Canaccord Genuity Downgrades Exact Sciences to Hold, Raises Price Target to $105

Benzinga · 11/25/2025 13:19
Canaccord Genuity analyst Kyle Mikson downgrades Exact Sciences (NASDAQ:EXAS) from Buy to Hold and raises the price target from $85 to $105.